The diagnosis matters first
Unnecessary treatment exposes a patient to risk without a clear clinical benefit. Responsible TRT begins with compatible symptoms, consistently low testosterone, and an evaluation of the likely cause.
Risks worth discussing plainly
- Increased hematocrit, which can require a dose change, pause, or further evaluation
- Reduced sperm production and impaired fertility
- Acne, oily skin, breast symptoms, fluid retention, or testicular shrinkage
- Worsening of untreated severe sleep apnea or certain urinary symptoms
- The need for prostate-risk discussion and monitoring when appropriate
- Uncertainty that remains around some long-term outcomes
Some patients should not start without more evaluation
Guidelines identify situations in which testosterone should be avoided or delayed, including a near-term desire for fertility and certain prostate, breast, blood-count, cardiovascular, sleep, and clotting concerns. Your history determines which of these matter.
Monitoring is the safety system
Follow-up is not “hassle.” It is how the provider checks response, dosing, side effects, testosterone level, and safety markers. A clinic that promises medication with minimal assessment is removing the part that makes ongoing care safer.
The bottom line
TRT is neither universally dangerous nor automatically safe. It is a medical treatment whose risk-benefit balance must be individualized and revisited over time.